Skip to main content
logo
CF PharmTech, Inc. (HKG:2652)
Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
5.30
-0.33 (-5.86%)
Oct 30, 2026, 4:08 PM HKT

CF PharmTech Ratios and Metrics

Millions HKD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Oct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Market Capitalization
2,26514,417----
Market Cap Growth
-80.72%-----
Enterprise Value
1,93414,168----
Last Close Price
5.3035.00----

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Oct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PE Ratio
-5213.44----
PS Ratio
4.4929.95----
PB Ratio
1.468.82----
P/TBV Ratio
1.658.96----

EV Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Oct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
EV/Sales Ratio
3.8329.44----
EV/EBITDA Ratio
26.49297.17----

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Oct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Debt / Equity Ratio
0.160.100.080.020.000.00
Debt / EBITDA Ratio
3.293.091.270.40--
Debt / FCF Ratio
---13.26--
Net Debt / Equity Ratio
-0.21-0.35-0.29-0.42-0.37-0.43
Net Debt / EBITDA Ratio
-4.74-11.92-4.77-7.626.122.00
Net Debt / FCF Ratio
1.762.293.83-232.946.901.55
Asset Turnover
-0.280.510.520.350.04
Inventory Turnover
-2.492.803.163.471.84
Quick Ratio
2.804.241.582.402.375.24
Current Ratio
3.214.591.882.893.536.25
Return on Equity (ROE)
-0.21%2.28%3.58%-5.62%-13.82%
Return on Assets (ROA)
--0.83%0.18%0.13%-5.34%-13.19%
Return on Capital Employed (ROCE)
-0.60%-1.30%0.30%0.20%-9.80%-23.70%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Oct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Earnings Yield
-0.37%0.02%----
FCF Yield
-8.32%-1.72%----
Buyback Yield / Dilution
-7.21%-1.85%----